Introduction {#sec1-1}
============

Dural arteriovenous fistulas (DAVFs) are the most common vascular malformations of the spine that may be difficult to properly diagnose, they account for approximately 80% of spinal AV malformations (AVMs). Initially described by Djindjan in 1977,\[[@ref1]\] AVFs at the filum terminale (FTAVFs) have been classified as type IV intradural perimedullary AVFs, and account for only 3% of spinal vascular malformations. To the best of our knowledge, 47 cases of FTAVF have been reported so far in the English literature from 1977 to January 2019 \[[Table 1](#T1){ref-type="table"}\]. This report describes the case of a patient with an FTAVF, and the reasoning that allowed the diagnosis and possible therapies proposed with a final satisfactory surgical approach.

###### 

Summary of cases (FTAVF) reported in the literature

  *n*°   Authors (years)                             Age (years)/sex   Length of symptoms (months)   Feeders            Location   Treatment   Outcome
  ------ ------------------------------------------- ----------------- ----------------------------- ------------------ ---------- ----------- ---------
  1      Djindjian *et al*. (1977)\[[@ref1]\]        37/male           12                            ASA                L2         S           PR
  2                                                  40/female         48                            ASA+LSA            L3         S           SS
  3      Gueguen *et al*. (1987)\[[@ref11]\]         40/female         36                            ASA (T8)           L3         S           SS
  4                                                  24/female         15                            ASA (T9)           L2         S           ↑
  5      Meisel *et al*. (1995)\[[@ref12]\]          30/male                                         ASA                L2         S           ↑
  6      Tender *et al*. (2005)\[[@ref13]\]          70/male           84                            ASA (T8)           L4         S           ↑
  7                                                  58/male           12                            ASA (T9)           L2         S           ↑
  8      Mitha *et al*. (2006)\[[@ref9]\]            42/male           84                                               S1         S           ↑
  9      Jin *et al*. (2010)\[[@ref14]\]             61/male           120                           LSA                L5/S1      S           ↑
  10     Witiw *et al*. (2011)\[[@ref15]\]           62/male           6                             ASA (T8)           S2/3       S           ↑ (PSD)
  11     Lim *et al*. (2011)\[[@ref16]\]             60/male           36                            ASA (L1)           L3         S           ↑
  12                                                 48/male                                         ASA (T10)          L4/5       S           ↑
  13                                                 53/female                                       ASA (L1)           L4/5       E           PR
  14                                                 63/female                                       ASA (L4) + LSA     L3/4       E           ↑ (PSD)
  15     Trinh and Duckworth (2011)\[[@ref17]\]      57/male           24                                                          S           ↑
  16                                                 63/male           48                                               L4/5       E           ↑
  17     Saito *et al*. (2011)\[[@ref18]\]           68/male           ND                            ASA (T9) + LSA     ND         S           ↑
  18     Kumar *et al*. (2011)\[[@ref19]\]           44/male           8                             ASA (T9)                      S           ↑
  19     Haddad *et al*. (2012)\[[@ref20]\]          60/male           12                            ASA (T11)          S1         E           ↑
  20     Takami *et al*. (2012)\[[@ref21]\]          66/female         6                             ASA (L1)           L2         S           ↑
  21                                                 63/male           36                            ASA (T11)          L2/3       S           ↑
  22     Fischer *et al*. (2013)\[[@ref22]\]         69/male           \>12                          ASA (T9)           L4         S           ↑ (PSD)
  23     Macht *et al*. (2012)\[[@ref23]\]           57/male           1                             LSA (S2)           S3/4       E           ↑
  24     Chanthanaphak *et al*. (2013)\[[@ref24]\]   70/female         6                             ASA (T12)          L5         E           ↑
  25                                                 55/male           12                            ASA (T10)          L4         E           ↑
  26                                                 63/male           4                             ASA (T11)          L5         S           ↑
  27                                                 39/female         2                             ASA (T11)          L2/3       E           ↑
  28                                                 31/male           24                            ASA (T10)          L2/3       E           ↑
  29                                                 67/male           12                            ASA (T9)           L3         E           ↑
  30                                                 72/male           12                            ASA (L1)           L5         E           ↑
  31                                                 57/female         18                            ASA (L4)           S2         S           ↑ (PSD)
  32                                                 66/male           12                            ASA (T9)           L2         S           ↑
  33                                                 62/male           6                             ASA (T8)           S2/3       S           ↑
  34     Takeuchi *et al*. (2014)\[[@ref8]\]         71/male           60                            ASA (T9)           L4         S           ↑
  35     Krishnan *et al*. (2013)\[[@ref25]\]        54/male           36                            ASA (T12)          L4         S           ↑
  36     Sharma *et al*. (2014)\[[@ref26]\]          48/male           132                           ASA (T9)           L4/5       S           ↑
  37     Wajima *et al*. (2017)\[[@ref7]\]           78/male           12                            ASA (T8/9) + LSA   S1/2       S           ↑
  38     Sharma *et al*. (2016)\[[@ref27]\]          42/male           48                            ASA (L3)           L3         S           ND
  39     Ding *et al*. (2016)\[[@ref10]\]            43/male           24                            ASA (L1)           L3         S           ↑
  40     Li *et al*. (2017)\[[@ref4]\]               65/male           48                            ASA (L2)           L2         S           ↑
  41     Lamsam *et al*. (2018)\[[@ref28]\]          50/male           12                            ASA (L2)           L2         S           ↑
  42     Takai *et al*. (2019)\[[@ref29]\]           73/male           24                            ASA (T10)          L2         S           ↓
  43                                                 63/female         24                            ASA (L1)           L3         S           ↓
  44                                                 76/male           48                            ASA (T10)          L5         S           ↓
  45                                                 84/male           24                            ASA                L4         S           ↓
  46     Hong *et al*. (2018)\[[@ref5]\]             45/male           12                            ASA (T10)          L2/3       S           ↑
  47                                                 31/male           8                             ASA                L2         S           ↑
  48     Lakhdar *et al*. (2019) (present case)      45/male           43                                                          S           ↑

S -- Surgery; E -- Embolization; ↑ -- Improvement; PR--Partial recovery; SS -- Symptom stabilization; PSD -- Persistent sphyncteral/sexual disturbance; ASA -- Anterior spinal artery; LSA -- Lateral spinal artery; ↑ -- Deterioration

Case Report {#sec1-2}
===========

History and presentation {#sec2-1}
------------------------

A 4-year-old male had no particular previous medical history of trauma, surgery, or any other chronic disease, presented with history, of intermittent and insidious low back pain radiating to both lower limbs for the past 2 years. This symptomatology was not getting relieved despite analgesics and physiotherapy modalities, all evolving toward gait disturbance with sciatic pain, paresthesia in both lower limbs, and sphincter disorder (pollakiuria). Assessment of her neurological condition revealed paraparesis a Grade 3 of the modified McCormick functional schema and a Grade 3 of the sensory pain scale.

The association of these symptoms suggested a cauda equina syndrome, and magnetic resonance imaging (MRI) was performed. T2-weighted MRI revealed the presence of a high intramedullary signal at the level of the thoracolumbar cord predominating at the conus that was associated with abnormal flow voids suggesting the tortuous and dilated perimedullary vessels as a sign of chronic venous congestion.

On T1-W1, spinal cord hypersignal changes that enhanced strongly after injection with gadolinium. These radiological features evoked a spinal vascular malformation excluding other differential diagnosis, mostly a tumoral etiology \[[Figure 1](#F1){ref-type="fig"}\]. Thereby, a spinal angiogram was done, which showed FTAVF at the lower lumbosacral region with fistulous point projected along the fifth lumbar spine (L5). The AVF was between the distal anterior spinal artery (ASA) and an early filling enlarged and tortuous vein returning cranially along the FT \[[Figure 2](#F2){ref-type="fig"}\]. The diagnosis of a FTAVF was thus definitively confirmed.

![Sagittal (a) T2-weighted, axial (b) and sagittal (c) postcontrast T1-weighted spinal magnetic resonance imaging, showing a high signal intense lesion in the conus medullaris, with increased flow voids over the spinal cord with more evident venous tortuosity and dilated vessels in the subarachnoid space](AJNS-14-1277-g001){#F1}

![Spinal angiogram shows an arteriovenous fistula of the filum terminale at L4--L5 level](AJNS-14-1277-g002){#F2}

Operation and postoperative course {#sec2-2}
----------------------------------

The therapeutic management options of our patient included surgical or endovascular treatment. Both methods have to identify and disconnect the draining vein to complete interruption of the shunt and to fix the lesion. In the present case, we preferred surgery because the distal anatomical location of the shunt even if embolization is technically possible but carries some risks to distal navigation of the microcatheter in the ASA and difficulties inherent to the small caliber of the feeding artery and the tortuosity. However, we elected for a simple surgical approach through a total laminectomy L5 and partial laminectomy L4 with the removal of the ligamentum flavum, to expose the dura. After opening the dura mater and arachnoid dissection, the roots of the cauda equine are gently displaced to expose the filum. Moreover, the fistula was easily identified. Since the vessels and nerve roots adhered to each other around the fistula, the draining vein was clipped.

The postoperative course was uneventful with successful complete obliteration of shunt vessels. The patient experienced symptomatic improvement postoperatively and at the last follow-up of 1 year later, he was independent for all activities of daily living without any neurological deficit.

On postoperative spinal angiography, the feeding artery (proximal radicular artery) was invisible at the bottom of the conus medullaris and the draining vein was not demonstrated.

Discussion {#sec1-3}
==========

FTAVF are uncommon intradural direct arteriovenous shunt, generally characterized by a single direct communication between the distal caudal continuation of the ASA, the artery of the FT and a single ascending vein which then ascends along the filum. According to the anatomical space in which spinal cord vascular malformations develop, four groups of lesions may be described: paraspinal; epidural; dural; and intradural.\[[@ref2][@ref3]\] Therefore, from the anatomic and embryologic view, FTAVFs are usually classified as "perimedullary fistulas."

Pathogenesis and histopathology {#sec2-3}
-------------------------------

The pathogenesis of FTAVF still remains unclear with no direct evidence supporting either an acquired or congenital etiology for these lesions. Although some authors speculate that FTAVF is congenital,\[[@ref4][@ref5]\] others believe that FTAVF may be of acquired origin and created by some angiogenic phenomena because most patients present in the latter half of adulthood. It is widely agreed that FTAVF is often presenting with symptoms secondary to venous hypertension and congestive myelopathy. However, some authors report that venous hypertension could cause a secondary AVF.\[[@ref6]\]

Although it is rare, FTAVFs could have multiple shunt points along the FT.\[[@ref5]\] Less commonly, FTAVF can be fed by branches of the lateral and/or the middle sacral arteries which can, in fact, supply the filum.\[[@ref7]\]

Microscopic examination of the fistulous point demonstrates an arterialization of the proximal draining vein,\[[@ref8]\] muscular layer abnormalities, and a fragmented internal elastic lamina of the markedly dilated vein.\[[@ref9]\]

Epidemiology and clinical manifestations {#sec2-4}
----------------------------------------

FTAVF represented only 3.1% of all intradural AVF,\[[@ref10]\] and \<5% of spinal intradural AVMs.\[[@ref10]\] FTAVF commonly present in male (79%), sex ratio 3.8, with median age of 56 years \[[Table 1](#T1){ref-type="table"}\].

As in other spinal vascular malformations, these lesions are important neurological entities because the myelopathy seen in FTAVF patients is related to an ascending congestive venopathy, vascular hypertension, and a putative chronic steal phenomenon. Indeed, they could result in progressive Foix--Alajouanine syndrome.\[[@ref5][@ref6][@ref30]\] However, this slowly progressive myelopathy requires a high degree of suspicion to diagnose cause FTVAF are often misdiagnosed with polyneuropathy or as the result of spine degenerative disease (\~20% of cases).\[[@ref31]\] Furthermore, few cases have been misdiagnosed and operated for lumbar stenosis and disc prolapse resulting in a failed back surgery syndrome.\[[@ref27]\] Interestingly, hemorrhage has never been reported as a mode of presentation in association with this subtype of spinal vascular malformation.\[[@ref6]\]

Imaging {#sec2-5}
-------

Spinal MRI demonstrates increased flow voids and T2 changes involving the conus and the FT. Furthermore, prominent vascular flow voids (46%) and vascular enhancement (67%) are extremely common.\[[@ref6]\] As MRI findings are often nonspecific and may sometimes fail to precisely assess the shunt zone, the spinal angiogram is often of considerable help for a proper diagnosis, to localize exactly the site of the fistula and to precisely define the angioarchitecture.

On spinal angiography, FTAVF is generally characterized by a focal, single-hole fistula located well below the conus in the lower lumbar spine. It can be helpful in differentiating these lesions from DAVF and epidural AVF. A good knowledge of angioarchitecture and anatomy gave a proper appreciation of the AV shunt and allowed the appropriate treatment strategy to be made.

Treatment {#sec2-6}
---------

The ultimate treatment goal of FTAVF consists of complete obliteration of the direct AV shunt with preservation of the normal spinal cord circulation. Both surgical and endovascular embolization are safe and effective therapeutic modalities in achieving complete interruption of the shunt. Indeed, the key factor in treating these lesions is safe isolation of the feeding artery, nidus, and draining vein. Some authors suggest that the distance from the top of the arterial feeder to the fistulous point is determining factor for the choice of treatment.\[[@ref7][@ref21]\] However, because of distal location, the very small caliber of the feeding artery and the tortuosity, endovascular therapy with safe catheterization proximal to the actual AV connection is often not feasible; and thus, surgery is often the preferred treatment. Endovascular treatment in the form of embolization may be associated with high risk related to distal navigation of the microcatheter and tearing or occlusion of ASA, or its branches in FTAVFs, causing thrombosis and vasospasm. Sometimes, endovascular procedure is technically difficult because of the small caliber of the ASA and the long distance between the origin of the radiculomedullary artery and the fistula. While, microsurgery is considered to be a first-line treatment, more favorable for avoiding arterial ischemic complications despite some risks of injury or occlusion of normal spinal vessels. Furthermore, we recommend surgical treatment considering the low morbidity and the high occlusion rates.\[[@ref6]\]

Surgical treatment is very effective and safe technique for most of these lesions as approximately 77% of the cases in the literature have been treated surgically \[[Table 1](#T1){ref-type="table"}\]. The surgical strategy of FTAVFs by ligation or clipping as in our case should include sufficient laminectomy and disconnection of all shunts. After posterior midline exposure at the lumbar level of fistula, dural opening, and arachnoid dissection, the fistula was identified, and the feeding artery and draining vein were coagulated.

Furthermore, some authors report three successful cases of sectioning of the filum above the fistulous point, considering that the FT has no neurologic function.\[[@ref15]\] Therefore, the resection of the FT requires a distance of \>2 cm from the normal distal end.\[[@ref8]\]

The authors also illustrate the benefits of repeated indocyanine green (ICG) fluorescein angiography, which is technically feasible, safe, and helpful in identifying vascular angioarchitecture.\[[@ref28]\] Although vascular flow and identification of crucial landmarks also need to be ensured with intraoperative image guidance.\[[@ref21]\] Some authors use the monitoring of somatosensory and motor evoked potentials to secure good clinical outcomes and to avoid spinal cord infarct. However, both intraoperative ICG video angiography and intraoperative neuromonitoring have not been used in this case.

Outcome and follow-up {#sec2-7}
---------------------

Regardless of the modality of treatment, after the obliteration of FTAVF, the pressure in the spinal veins will decrease, which invariably results in progressive improvement or at least stabilization of symptoms\[[@ref3]\] \[[Table 2](#T2){ref-type="table"}\]. The majority of patients (81%) will experience improvement of their motor and sensory symptoms \[[Table 2](#T2){ref-type="table"}\]. Although bladder and bowel dysfunction are less likely to improve,\[[@ref28]\] there is often not a direct correlation between radiological and clinical improvement.\[[@ref16]\]

###### 

Outcome and postoperatory clinical status for all cases of the literature

  Outcome       Rate (%)
  ------------- ----------
  Improvement   81
  PR            4
  SS            4
  Aggravation   8

PR -- Partial recovery; SS -- Symptom stabilization

Conclusion {#sec1-4}
==========

Besides being a rare entity with no specific clinical manifestations, FTAVF can be successfully treated using multidisciplinary approaches. Surgery is often the primary choice in most cases with good results, especially in progressive neurologic deficit.
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